News

Adrenal gland tumor surgery safe in pregnant woman: Case report

A pregnant woman underwent a successful laparoscopic adrenalectomy, a minimally invasive surgery to remove tumors in the adrenal glands, for Cushing’s syndrome which was caused by such a tumor and resolved, according to a case report. Although it is the standard treatment for adrenal tumors, laparoscopic adrenalectomy is not commonly done…

Dexamethasone suppression failed to help detect tumors in Cushing’s

Dexamethasone suppression did not improve the detection of pituitary tumors via the use of PET, or positron emission tomography, scans in adults with Cushing’s disease, a new study has found. In most cases, using imaging tests to determine tumor location before pituitary surgery — the first-line treatment for Cushing’s…

Case of exogenous Cushing’s sparks warnings of herbal supplement

A 44-year-old man developed exogenous, or treatment-related, Cushing’s syndrome, after taking an herbal supplement called Nhan Sam Tuyet Lien, which contained undisclosed amounts of glucocorticoids, a case study reports. His symptoms eased after he stopped taking the supplement and started taking prednisone. “This case highlights the importance of history taking…

Gene activity changes in fatty tissue linked to high blood pressure

Alterations in the activity of a signaling system called RAAS in fatty tissue could contribute to high blood pressure in people with Cushing’s syndrome, according to a recent report. Data showed gene activity associated with renin-angiotensin-aldosterone-system (RAAS) was altered in fatty tissue from Cushing’s patients relative to people without the…

Tumor removal surgery seen to benefit Cushing’s patients in study

While people with Cushing’s syndrome often experience hypertension, or high blood pressure, and diabetes — two conditions that put them at higher risk of developing cardiovascular diseases — tumor removal surgery was found to ease these conditions in a new study from Tunisia. Indeed, most patients saw improvements within one…

Isturisa found to be safe, effective in long-term trial extension

Long-term treatment with Isturisa (osilodrostat) led to a sustained normalization in cortisol levels, symptom relief, and improved quality of life for people with Cushing’s disease, according to the full results from the LINC 4 clinical trial and its extension phase. “These data provide further evidence of the durable clinical…